Where is EFFEX located?

EFFEX is headquartered in Leuven, Belgium.

Is EFFEX a funded company?

EFFEX is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does EFFEX rank among its competitors?

EFFEX ranks 28th amongst 133 active competitors, of which 28 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sinopia Biosciences, which secured an undisclosed amount in Mar, 2026.

Who are the top competitors of EFFEX?

EFFEX's top competitors include NantHealth, BioAge Labs and Genedata. Among them, Sinopia Biosciences secured the most recent funding round in March, 2026.

EFFEX - 2026 Company Profile, Team & Competitors

EFFEX is an acquired company based in Leuven (Belgium), founded in 2023 by David Martínez Barreiro and Bart De Ketelaere. It operates as a Web-based solution for experimental design and collaboration offering experimental plans. The company has 133 active competitors, including 28 funded and 12 that have exited. Its top competitors include companies like NantHealth, BioAge Labs and Genedata.

Company Details

Web-based solution for experimental design and collaboration offering experimental plans. It offers a cloud-based software that allows customers to work in pharma, the chemical sector, manufacturing or food, to define the tests, and collect the data to plan and analyse the experiments.

Website: effex.app
Phone Number: +32 **********

Key Metrics

Founded Year

2023

Location

Leuven, Belgium

Stage

Acquired

Ranked

28^th among 133 active competitors

Similar Companies

NantHealth & 167 more

Exit Details

Acquired by Minitab (Feb 18, 2026)

View EFFEX's full profile

EFFEX got acquired by Minitab on Feb 18, 2026.

Click here to take a look at EFFEX's acquisition in detail

EFFEX has not raised any funding rounds yet.

The founders of EFFEX are David Martínez Barreiro and Bart De Ketelaere.

Here are the details of EFFEX's key team members:

David Martínez Barreiro: Co-Founder of EFFEX.
Bart De Ketelaere: Co-Founder of EFFEX.

View details of EFFEX's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EFFEX include NantHealth, BioAge Labs and Genedata. Here is the list of Top 10 competitors of EFFEX, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NantHealth 2007, El Segundo (United States), Public	Provider of bioinformatics platform to find treatment for cancer and other diseases	$608M	Verizon, Allscripts & 6 others	65/100
2nd	BioAge Labs 2015, Vallejo (United States), Public	Provider of a bioinformatics platform for biomarkers and drug discovery	$294M	Andreessen Horowitz, Felicis Ventures & 26 others	61/100
3rd	Genedata 1997, Basel (Switzerland), Acquired	Software solutions for drug discovery, industrial biotechnology, and life science research	-	Novartis Venture Fund, Alta Partners & 1 others	58/100
4th	Ontoforce 2011, Ghent (Belgium), Series B	Provider of semantic search platform for pharmaceutical and biotech research	$12.7M	SoFi, imec.istart & 8 others	53/100
5th	NashBio 2018, Nashville (United States), Unfunded	Provider of multimodal dataset for drug development	-	-	51/100
6th	Syntekabio 2009, Sunnyvale (United States), Public	AI-driven drug discovery and development, SaaS platform, supercomputing center	$11.1M	Yozma Group Korea, Korea Development Bank Europe ... & 5 others	50/100
7th	Sinopia Biosciences 2014, San Diego (United States), Funding Raised	Data-driven drug discovery using multi-omics, AI, and disease models	-	National Cancer Institute, JLABS & 4 others	48/100
8th	Perthera 2012, Mclean (United States), Series A	Personalized molecular cancer profiling through genomics and proteomics	$17.8M	Pilot Growth Equity, Invictus Growth	48/100
9th	Century Health 2023, Santa Monica (United States), Seed	AI-powered health tech company accelerating access to breakthrough treatments	$2M	2048 Ventures, Life Extension Ventures & 4 others	47/100
10th	Dandelion Health 2020, New York City (United States), Seed	Provider of AI-powered real-world data platform for clinical development	$15.9M	Primary Venture Partner, Floating Point & 4 others	46/100
28th	EFFEX 2023, Leuven (Belgium), Acquired	Web-based solution for experimental design and collaboration offering experimental plans	-	-	34/100